{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:42:44Z","timestamp":1792590164415,"version":"4.5.0"},"reference-count":28,"publisher":"MyJove Corporation","issue":"230","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70047","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:00:51Z","timestamp":1775257251000},"source":"Crossref","is-referenced-by-count":1,"title":["Serum Insulin-like Growth Factor-1 and Growth Hormone as Potential Diagnostic Biomarkers for Postmenopausal Osteoporosis Among Chinese Women"],"prefix":"10.3791","author":[{"given":"Hairong","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binxiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41574-020-0339-7","type":"journal-article","article-title":"A broader strategy for osteoporosis interventions","volume":"16","author":"Ruff","year":"2020","unstructured":"Ruff, I. R. A broader strategy for osteoporosis interventions. Nat. Rev. Endocrinol. 16 (6), 333-339 (2020).","journal-title":"Nat. Rev. Endocrinol"},{"issue":"21","key":"ref2","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","type":"journal-article","article-title":"Postmenopausal osteoporosis","volume":"389","author":"Wright","year":"2023","unstructured":"Wright, M. D., Stone, E. Postmenopausal osteoporosis. N. Engl. J. Med. 389 (21), 1979-1991 (2023).","journal-title":"N. Engl. J. Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"106930","DOI":"10.1016\/j.phrs.2023.106930","type":"journal-article","article-title":"Estrogen deficiency induces bone loss through the gut microbiota","volume":"196","author":"Guo","year":"2023","unstructured":"Guo, Z., Xu, Z., Zhang, J. et al. Estrogen deficiency induces bone loss through the gut microbiota. Pharmacol. Res. 196, 106930 (2023).","journal-title":"Pharmacol. Res"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12020-021-02806-x","type":"journal-article","article-title":"DXA parameters, trabecular bone score (TBS) and bone mineral density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis","volume":"74","author":"Shevroja","year":"2021","unstructured":"Shevroja, E., Cafarelli, F. P., Guglielmi, G. et al. DXA parameters, trabecular bone score (TBS) and bone mineral density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis. Endocrine. 74 (1), 20-28 (2021).","journal-title":"Endocrine"},{"key":"ref5","first-page":"299","type":"journal-article","article-title":"Low-molecular-weight estrogenic phytoprotein suppresses osteoporosis development through positive modulation of skeletal estrogen receptors","volume":"42","author":"Kubi","year":"2024","unstructured":"Kubi, J. A., Brah, A. S., Cheung, K. M. C. et al. Low-molecular-weight estrogenic phytoprotein suppresses osteoporosis development through positive modulation of skeletal estrogen receptors. Bioact. Mater. 42, 299-315 (2024).","journal-title":"Bioact. Mater"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s10020-024-00968-8","type":"journal-article","article-title":"Increased levels of versican and insulin-like growth factor 1 in peritumoral mammary adipose tissue are related to aggressiveness in estrogen receptor-positive breast cancer","volume":"30","author":"Mirra","year":"2024","unstructured":"Mirra, P., Parascandolo, A., Marino, G. et al. Increased levels of versican and insulin-like growth factor 1 in peritumoral mammary adipose tissue are related to aggressiveness in estrogen receptor-positive breast cancer. Mol. Med. 30 (1), 201 (2024).","journal-title":"Mol. Med"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"e2091188176","DOI":"10.1073\/pnas.2203779120","type":"journal-article","article-title":"marrow-derived IGF-1 orchestrates maintenance and regeneration of the adult skeleton","volume":"120","author":"Wang","year":"2023","unstructured":"Wang, J., Zhu, Q., Cao, D. et al. Bone marrow-derived IGF-1 orchestrates maintenance and regeneration of the adult skeleton. Proc. Natl. Acad. Sci. U.S.A. 120 (1), e2091188176 (2023).","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1210\/clinem\/dgab145","type":"journal-article","article-title":"Effect of transdermal estradiol and insulin-like growth factor-1 on bone endpoints of young women with anorexia nervosa","volume":"106","author":"Singhal","year":"2021","unstructured":"Singhal, V., Bose, A., Slattery, M. et al. Effect of transdermal estradiol and insulin-like growth factor-1 on bone endpoints of young women with anorexia nervosa. J. Clin. Endocrinol. Metab. 106 (7), 2021-2035 (2021).","journal-title":"J. Clin. Endocrinol. Metab"},{"issue":"7817","key":"ref9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41586-020-2502-7","type":"journal-article","article-title":"Fasting-mimicking diet and hormone therapy induce breast cancer regression","volume":"583","author":"Caffa","year":"2020","unstructured":"Caffa, I., Spagnolo, V., Vernieri, C. et al. Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature. 583 (7817), 620-624 (2020).","journal-title":"Nature"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"R269","DOI":"10.1530\/EJE-21-0155","type":"journal-article","article-title":"Mechanisms in endocrinology: Paracrine and endocrine control of the growth hormone axis by estrogen","volume":"184","author":"Birzniece","year":"2021","unstructured":"Birzniece, V., Ho, K. K. Y. Mechanisms in endocrinology: Paracrine and endocrine control of the growth hormone axis by estrogen. Eur. J. Endocrinol. 184 (6), R269-R278 (2021).","journal-title":"Eur. J. Endocrinol"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s11357-024-01426-3","type":"journal-article","article-title":"The impact of inactivation of the GH\/IGF axis during aging on health span","volume":"47","author":"Poudel","year":"2025","unstructured":"Poudel, S. B., Ruff, R. R., He, Z. et al. The impact of inactivation of the GH\/IGF axis during aging on health span. Geroscience. 47 (3), 3027-3042 (2025).","journal-title":"Geroscience"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ecl.2021.03.009","type":"journal-article","article-title":"Postmenopausal osteoporosis: Latest guidelines","volume":"50","author":"Arceo-Mendoza","year":"2021","unstructured":"Arceo-Mendoza, R. M., Camacho, P. M. Postmenopausal osteoporosis: Latest guidelines. Endocrinol. Metab. Clin. North Am. 50 (2), 167-178 (2021).","journal-title":"Endocrinol. Metab. Clin. North Am"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/endrev\/bnac031","type":"journal-article","article-title":"turnover markers: Basic biology to clinical applications","volume":"44","author":"Schini","year":"2023","unstructured":"Schini, M., Vilaca, T., Gossiel, F. et al. Bone turnover markers: Basic biology to clinical applications. Endocr. Rev. 44 (3), 417-473 (2023).","journal-title":"Endocr. Rev"},{"issue":"11","key":"ref14","first-page":"908","type":"journal-article","article-title":"Use of bone turnover markers in postmenopausal osteoporosis","volume":"5","author":"Eastell","year":"2017","unstructured":"Eastell, R., Szulc, P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet DiabetesEndocrinol. 5 (11), 908-923 (2017).","journal-title":"Lancet DiabetesEndocrinol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.clnu.2020.05.040","type":"journal-article","article-title":"The efficacy of different vitamin D supplementation delivery methods on serum 25(OH)D: A randomized double-blind placebo trial","volume":"40","author":"Wyon","year":"2021","unstructured":"Wyon, M. A., Wolman, R., Martin, C. et al. The efficacy of different vitamin D supplementation delivery methods on serum 25(OH)D: A randomized double-blind placebo trial. Clin. Nutr. 40 (2), 388-393 (2021).","journal-title":"Clin. Nutr"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4103\/0971-5916.169206","type":"journal-article","article-title":"Relation of serum 25 hydroxyvitamin D levels to bone mineral density in southern Chinese postmenopausal women: A preliminary study","volume":"142","author":"Deng","year":"2015","unstructured":"Deng, W. M., Wei, Q. S., Tan, X. et al. Relation of serum 25 hydroxyvitamin D levels to bone mineral density in southern Chinese postmenopausal women: A preliminary study. Indian J. Med. Res. 142 (4), 430-437 (2015).","journal-title":"Indian J. Med. Res"},{"issue":"12","key":"ref17","first-page":"CD013046","type":"journal-article","article-title":"Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health","volume":"12","author":"Tan","year":"2020","unstructured":"Tan, M. L., Abrams, S. A., Osborn, D. A. Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health. Cochrane Database Syst. Rev. 12 (12), CD013046 (2020).","journal-title":"Cochrane Database Syst. Rev"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jaci.2019.01.004","type":"journal-article","article-title":"Vitamin D is no substitute for the sun","volume":"143","author":"Matsushima","year":"2019","unstructured":"Matsushima, Y., Mizutani, K., Yamaguchi, Y. et al. Vitamin D is no substitute for the sun. J. Allergy Clin. Immunol. 143 (3), 929-931 (2019).","journal-title":"J. Allergy Clin. Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"124125","DOI":"10.1016\/j.ijbiomac.2023.124125","type":"journal-article","article-title":"The role of insulin-like growth factor-1 in bone remodeling: A review","volume":"238","author":"Fang","year":"2023","unstructured":"Fang, J., Zhang, X., Chen, X. et al. The role of insulin-like growth factor-1 in bone remodeling: A review. Int. J. Biol. Macromol. 238, 124125 (2023).","journal-title":"Int. J. Biol. Macromol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.joca.2016.09.010","type":"journal-article","article-title":"The effects of different doses of IGF-1 on cartilage and subchondral bone during the repair of full-thickness articular cartilage defects in rabbits","volume":"25","author":"Zhang","year":"2017","unstructured":"Zhang, Z., Li, L., Yang, W. et al. The effects of different doses of IGF-1 on cartilage and subchondral bone during the repair of full-thickness articular cartilage defects in rabbits. Osteoarthritis Cartilage. 25 (2), 309-320 (2017).","journal-title":"Osteoarthritis Cartilage"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/ard-2023-224385","type":"journal-article","article-title":"Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice","volume":"82","author":"Collins","year":"2023","unstructured":"Collins, J. A., Kim, C. J., Coleman, A. et al. Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice. Ann. Rheum. Dis. 82 (11), 1464-1473 (2023).","journal-title":"Ann. Rheum. Dis"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"101927","DOI":"10.1016\/j.xcrm.2024.101927","type":"journal-article","article-title":"Disrupting AGR2\/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy","volume":"6","author":"Li","year":"2025","unstructured":"Li, H., Zhang, Z., Shi, Z. et al. Disrupting AGR2\/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. Cell Rep. Med. 6 (2), 101927 (2025).","journal-title":"Cell Rep. Med"},{"issue":"9","key":"ref23","first-page":"2749","type":"journal-article","article-title":"Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management","volume":"11","author":"Tang","year":"2021","unstructured":"Tang, G., Li, S., Zhang, C. et al. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Acta Pharm. Sin. B. 11 (9), 2749-2767 (2021).","journal-title":"Acta"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/ph16091320","type":"journal-article","article-title":"Effect of growth hormone and estrogen replacement therapy on bone mineral density in women with Turner syndrome: A meta-analysis and systematic review","volume":"16","author":"Szybiak","year":"2023","unstructured":"Szybiak, W., Kujawa, B., Miedziaszczyk, M. et al. Effect of growth hormone and estrogen replacement therapy on bone mineral density in women with Turner syndrome: A meta-analysis and systematic review. Pharmaceuticals. 16 (9), 1320 (2023).","journal-title":"Pharmaceuticals"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endrev\/bnac014","type":"journal-article","article-title":"Management of growth disorders in puberty: GH, GnRHa, and aromatase inhibitors: A clinical review","volume":"44","author":"Mauras","year":"2023","unstructured":"Mauras, N., Ross, J., Mericq, V. Management of growth disorders in puberty: GH, GnRHa, and aromatase inhibitors: A clinical review. Endocr. Rev. 44 (1), 1-13 (2023).","journal-title":"Endocr. Rev"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/endrev\/bnab015","type":"journal-article","article-title":"The relationship between bone and reproductive hormones beyond estrogens and androgens","volume":"42","author":"Mills","year":"2021","unstructured":"Mills, E. G., Yang, L., Nielsen, M. F. et al. The relationship between bone and reproductive hormones beyond estrogens and androgens. Endocr. Rev. 42 (6), 691-719 (2021).","journal-title":"Endocr. Rev"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.18632\/aging.204464","type":"journal-article","article-title":"A case-control study coupling with meta-analysis elaborates decisive association between IGF-1 rs35767 and osteoporosis in Asian postmenopausal females","volume":"15","author":"Su","year":"2023","unstructured":"Su, S. L., Huang, Y. H., Chen, Y. H. et al. A case-control study coupling with meta-analysis elaborates decisive association between IGF-1 rs35767 and osteoporosis in Asian postmenopausal females. Aging. 15. (1), 134-147 (2023).","journal-title":"Aging"},{"issue":"1","key":"ref28","first-page":"131","type":"journal-article","article-title":"The polymorphism of insulin-like growth factor-I (IGF-I) is related to osteoporosis and bone mineral density in postmenopausal population","volume":"30","author":"Li","year":"2014","unstructured":"Li, Y. K., Wang, H., Zhu, X. W. et al. The polymorphism of insulin-like growth factor-I (IGF-I) is related to osteoporosis and bone mineral density in postmenopausal population. Pak. J. Med. Sci. 30 .(1), 131-135 (2014).","journal-title":"Pak. J. Med. Sci"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/70047\/serum-insulin-like-growth-factor-1-growth-hormone-as-potential","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:04:15Z","timestamp":1792587855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70047\/serum-insulin-like-growth-factor-1-growth-hormone-as-potential"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":28,"journal-issue":{"issue":"230","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70047","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}